Stocktoria
Genprex, Inc. GNPX
Genprex, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | $0 | $0 | $0 | — | $0 | $0 | $0 |
| R&D expense | $9.4M | $10.5M | $17.6M | $11.5M | $9.0M | $7.3M | $2.0M | $971,427 | $289,934 | $354,883 |
| Operating income | -$15.5M | -$21.2M | -$31.1M | -$23.8M | -$20.7M | -$18.0M | -$10.7M | -$12.4M | -$3.3M | -$4.1M |
| Interest expense | — | — | — | — | — | — | — | $37,982 | $1,890 | $0 |
| Income tax | $0 | $2,650 | $0 | $0 | — | — | — | — | — | — |
| Net income | -$16.2M | -$21.1M | -$30.9M | -$23.7M | -$20.7M | -$17.9M | -$10.7M | -$12.4M | -$3.3M | -$4.1M |
| Operating cash flow | -$15.3M | -$17.9M | -$24.7M | -$17.6M | -$14.3M | -$13.9M | -$6.9M | -$6.8M | -$2.2M | -$1.2M |
| Free cash flow | — | — | — | -$17.6M | -$14.3M | -$14.0M | -$7.0M | -$6.9M | -$2.2M | -$1.3M |
| Cash & equivalents | $7.8M | $1.6M | $6.7M | $21.0M | $38.6M | $27.3M | — | — | $161,251 | $1.6M |
| Total assets | $10.2M | $4.1M | $10.7M | $25.1M | $42.9M | $31.4M | $3.5M | $9.3M | $1.3M | $1.9M |
| Total liabilities | $2.2M | $2.5M | — | — | $1.6M | — | — | — | — | — |
| Shareholders' equity | $8.0M | $1.6M | $7.4M | $22.3M | $41.3M | $30.9M | $3.0M | $8.9M | $428,574 | $1.6M |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.